Ethionamide Tablets

Developed to mitigate mycobacterial replication to support chronic tissue clearance and target resistant tuberculosis strains.

Dosage

Pack size

The exact manufacturer offered is confirmed by the fulfilment partner before supply.

Prescription and consultation requirements for Ethionamide Tablets vary by destination and are determined by the fulfilment partner.

Ethionamide Tablets details

Condition: Active Tuberculosis
Alternative names: trecator
Therapeutic class: Isotonic Hydrazide Derivative
Pharmacological class: Antitubercular Agent
Contraindications: severe hepatic impairment; hypersensitivity to ethionamide
Minor side effects: nausea; vomiting; abdominal pain
Moderate side effects: diarrhoea; postural hypotension; elevated liver enzymes
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Onset Time: 1–2 weeks
Duration: 12–24 hours
Storage instructions: Store below 25°C.
Drug interactions: Isoniazid; Rifadin
Age restrictions: Approved for children and adults.

Serious side effects

severe hepatotoxicity, requires immediate medical attention; severe peripheral neuropathy, requires immediate medical attention

Patient summary

developed to mitigate mycobacterial replication to support chronic tissue clearance and target resistant tuberculosis strains.

Mechanism of action

Disrupts cellular mycolic acid synthesis in the mycobacterial cell wall, preventing growth and cellular division.

Pregnancy and breastfeeding

TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a clinician.

Ethionamide Tablets is a generic medicine sold under the name of its active ingredient, Ethionamide, rather than under a brand.

The fulfilment partner confirms the offered manufacturer and product before supply.
Check the active ingredient, strength, form and pack shown at checkout before confirming an order.